Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Thoracic 1 Head & Neck 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Specimen Handling 46 Letrozole 40 Fulvestrant 39 Paclitaxel 38 pembrolizumab 32 Carboplatin 31 Magnetic Resonance Spectroscopy 30 ribociclib 25 Trastuzumab 25 Biopsy 24 exemestane 23 Anastrozole 23 Capecitabine 22 palbociclib 20 pertuzumab 19 Tamoxifen 18 trastuzumab deruxtecan 17 Cyclophosphamide 17 abemaciclib 16 Taxes 14 Radiotherapy 13 130-nm albumin-bound paclitaxel 12 elacestrant 10 sacituzumab govitecan 9 olaparib 9 Standard of Care 9 Radiation 9 Goserelin 9 Gemcitabine 9 Docetaxel 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

camrelizumab × Breast × 30 days × Clear all

NCT05582499 2026-05-28

FASCINATE-N

Fudan University

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡